Analyst Target Signals

Showing 5 signals. Updated 2026-02-13. Highlighting ADDYY.

Price$12.10
Signal$14.27|-15.2%|2026-01-12 09:47:00
Headline: Raymond James Reiterates Strong Buy Rating on Aardvark Therapeutics Inc (AARD)
TargetsPT $47.00 | Cons $31.00
UpsideImp +229.4% | Cons +117.2%
Price$1.13
Signal$1.51|-25.2%|2026-02-02 11:09:07
Headline: American Bitcoin initiated with a Buy at H.C. Wainwright
TargetsPT $4.00 | Cons $4.00
UpsideImp +164.9% | Cons +164.9%
Price$22.03
Signal$26.66|-17.4%|2026-01-06 13:38:07
Headline: Acadia Pharmaceuticals price target raised to $40 from $35 at UBS
TargetsPT $40.00 | Cons $34.71
UpsideImp +50.0% | Cons +30.2%
Price$3.19
Signal$3.43|-7.0%|2026-01-30 12:09:50
Headline: Craig-Hallum bullish on Aclaris Therapeutics, initiates with a Buy
TargetsPT $10.00 | Cons $10.00
UpsideImp +191.5% | Cons +191.5%
Price$91.07
Signal$93.92|-3.0%|2026-01-06 13:54:07
Headline: Adidas price target raised to $146.02 from $127.09 at Bernstein
TargetsPT $146.02 | Cons $146.02
UpsideImp +55.5% | Cons +55.5%
AARDAardvark Therapeutics, Inc. Common StockHealthcareBiotechnology$263.5M10Raymond James Reiterates Strong Buy Rating on Aardvark Therapeutics Inc (AARD)$47.00$14.84+229.4%$31.00+117.2%-15.2%2026-01-12
ABTCAmerican Bitcoin CorpFinancial ServicesFinancial - Capital Markets$1.0B10American Bitcoin initiated with a Buy at H.C. Wainwright$4.00$1.43+164.9%$4.00+164.9%-25.2%2026-02-02
ACADACADIA Pharmaceuticals Inc.HealthcareBiotechnology$3.7B7Acadia Pharmaceuticals price target raised to $40 from $35 at UBS$40.00$27.35+50.0%$34.71+30.2%-17.4%2026-01-06
ACRSAclaris Therapeutics, Inc.HealthcareMedical - Diagnostics & Research$345.6M10Craig-Hallum bullish on Aclaris Therapeutics, initiates with a Buy$10.00$3.51+191.6%$10.00+191.5%-7.0%2026-01-30
ADDYYadidas AGConsumer CyclicalApparel - Footwear & Accessories$32.5B8Adidas price target raised to $146.02 from $127.09 at Bernstein$146.02$94.10+55.5%$146.02+55.5%-3.0%2026-01-06